Aegis Biopharmaceuticals Inc. is a Canadian company established in 2021 and based in British Columbia. The company focuses on utilizing plant-based biotechnology to enhance human health and immune function. Its products leverage synthetic biology combined with natural ingredients to create solutions for various health challenges, including advanced wound care, dermatology, and supplements. Aegis specializes in the development of plant-based, vegan ingredients for immune support and wound healing. The company is a subsidiary of SignalChem Lifesciences Corp., a leader in protein kinase engineering and pharmaceutical research.